drugset / Trial / NCT01404572

Taste Assessment Study of 2 Atazanavir Powder Formulations in Healthy Subjects

NCT01404572

Phase 1 Completed 12 enrolled Bristol-Myers Squibb
RandomizedCrossoverDouble-blind

Summary

The purpose of this study is to compare the sweetness of 2 new atazanavir powder for oral use (POU) formulations to the current atazanavir POU in healthy participants and to select 1 atazanavir POU that has the sweetness most similar to the current atazanavir POU.

Timeline

Start
2011-08
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atazanavir Other / unclassified 15 mg Oral